Harwood Feffer LLP Announces Investigation of Continucare Corporation

Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Continucare Corporation (“Continucare”) (NYSE: CNU) concerning the proposed acquisition by Metropolitan Health Networks, Inc. (NYSE AMEX: MDF) (“Metropolitan”) for all of the outstanding shares of common stock of Continucare for $6.25 per share in cash and 0.0414 of a share of Metropolitan (which, based upon the share price at the time of the announcement, is equal to approximately $0.20). The transaction is currently valued at $416 million. In addition, shareholders who collectively own approximately 43% of Continucare stock have agreed to vote their shares in favor of the proposed merger.

Our investigation concerns whether the board of directors has undertaken a fair process to obtain fair consideration for all shareholders of Continucare.

If you own shares of Continucare and would like to learn more about these claims or if you wish to discuss this matter and have any questions or information concerning this announcement, please contact Robert I. Harwood, Esq. at rharwood@hfesq.com or James G. Flynn, Esq. at jflynn@hfesq.com. You may also call them at (877) 935-7400. For more information about class actions, or to sign up online, please visit our website: www.hfesq.com.

Harwood Feffer LLP is a national shareholder litigation firm. Harwood Feffer LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.

Attorney Advertising. ©2011 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Continuecare (NYSE:CNU)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025